U.S. PHARMACOPEIA

Search USP29  
Codeine Sulfate Tablets
» Codeine Sulfate Tablets contain not less than 93.0 percent and not more than 107.0 percent of the labeled amount of (C18H21NO3)2·H2SO4·3H2O.
Packaging and storage— Preserve in well-closed containers.
Identification—
A: Digest a quantity of finely powdered Tablets, equivalent to about 50 mg of codeine sulfate, with 15 mL of water and 5 mL of 2 N sulfuric acid for 1 hour. Filter, if necessary, and wash any undissolved residue with a few mL of water. Render the filtrate alkaline with 6 N ammonium hydroxide, extract with several small portions of chloroform, and evaporate the chloroform solution on a steam bath to dryness: the resulting residue of codeine responds to Identification test A under Codeine.
B: A filtered solution of Tablets responds to the tests for Sulfate 191.
Dissolution 711
Medium: water; 500 mL.
Apparatus 1: 100 rpm.
Time: 45 minutes.
Procedure— Determine the amount of (C18H21NO3)2·H2SO4·3H2O dissolved from UV absorbances at the wavelength of maximum absorbance at about 284 nm on filtered portions of the solution under test, suitably diluted with water, if necessary, in comparison with a Standard solution having a known concentration of USP Codeine Sulfate RS in the same Medium.
Tolerances— Not less than 75% (Q) of the labeled amount of (C18H21NO3)2·H2SO4·3H2O is dissolved in 45 minutes.
Uniformity of dosage units 905: meet the requirements.
Procedure for content uniformity— Transfer 1 Tablet to a 50-mL volumetric flask. Add 20 mL of 0.5 N sulfuric acid and 10 mL of water, shake until the Tablet is disintegrated, and allow to stand for 16 hours. Dilute with water to volume, and filter, discarding the first few mL of the filtrate. Dilute a portion of the subsequent filtrate quantitatively and stepwise, if necessary, with 0.2 N sulfuric acid to obtain a solution containing approximately 120 µg of codeine sulfate (trihydrate) per mL. Concomitantly determine the absorbances of this solution and a Standard solution of USP Codeine Sulfate RS in the same medium having a known concentration of about 110 µg per mL, in 1-cm cells, at the wavelength of maximum absorbance at about 284 nm, with a suitable spectrophotometer, using 0.2 N sulfuric acid as the blank. Calculate the quantity, in mg, of (C18H21NO3)2·H2SO4·3H2O in the Tablet taken by the formula:
(750.87 / 696.82)(TC / D)(AU / AS),
in which 750.87 and 696.82 are the molecular weights of codeine sulfate trihydrate and anhydrous codeine sulfate, respectively; T is the labeled quantity, in mg, of codeine sulfate in the Tablet; C is the concentration, in µg per mL, of USP Codeine Sulfate RS in the Standard solution; D is the concentration, in µg per mL, of codeine sulfate in the test solution, based upon the labeled quantity per Tablet and the extent of dilution; and AU and AS are the absorbances of the test solution and the Standard solution, respectively.
Residual solvents 467: meet the requirements.
(Official January 1, 2007)
Assay— Weigh and finely powder not fewer than 20 Tablets. Accurately weigh a portion of the powder, equivalent to about 150 mg of codeine sulfate, and transfer it completely to a 100-mL volumetric flask. Add sufficient water to make a thin suspension, then add 20 mL of 0.5 N sulfuric acid, shake the mixture occasionally for 2 hours, and allow to stand for 16 hours. Dilute with water to volume, mix, and filter through a filtering crucible. Transfer an accurately measured portion of the filtrate, equivalent to not less than 75 mg of codeine sulfate, to a separator, render the solution alkaline with 6 N ammonium hydroxide, and completely extract the alkaloid with successive 15-mL portions of chloroform. Evaporate the combined chloroform solution on a steam bath nearly to dryness, add 25.0 mL of 0.02 N sulfuric acid VS, and heat gently to dissolve the codeine and expel all of the chloroform. Cool, add methyl red TS, and titrate the excess acid with 0.02 N sodium hydroxide VS. Each mL of 0.02 N sulfuric acid is equivalent to 7.509 mg of (C18H21NO3)2·H2SO4·3H2O.
Auxiliary Information— Staff Liaison : Clydewyn M. Anthony, Ph.D., Scientist
Expert Committee : (MDCCA05) Monograph Development-Cough Cold and Analgesics
USP29–NF24 Page 585
Phone Number : 1-301-816-8139